A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Download All
In this comprehensive online program, experts discuss how to select optimal therapies for patients with B-cell lymphomas. Get up to date with expert commentaries, an on-demand webcast and slides from a dynamic CCO symposium at ASH 2021, downloadable resources on 10 key agent classes, and an audio podcast.
Julie M. Vose, MD, MBA
Program Director
Brad S. Kahl, MD
John P. Leonard, MD

On-Demand Webcast

In this on-demand webcast, Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, review the current treatment paradigm for B-cell lymphomas, including key updates from ASH 2021.

Julie M. Vose, MD, MBA
Program Director
Brad S. Kahl, MD John P. Leonard, MD
Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: February 7, 2022 Expired: February 6, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Atara Biotherapeutics, Inc.
Bayer HealthCare Pharmaceuticals Inc.
BeiGene, Ltd.
Epizyme
Genentech, a member of the Roche Group
Genmab US, Inc.
Incyte Corporation
Karyopharm Therapeutics
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings